复发/转移性乳腺癌的临床试验
总计17852个结果
-
National Cancer Institute (NCI)完全的
-
AstraZenecaDaiichi Sankyo尚未招聘
-
National Cancer Institute (NCI)完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)招聘中BRCA1基因突变 | BRCA2基因突变 | 复发性卵巢癌 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | III 期卵巢癌 AJCC v8 | IIIA 期卵巢癌 AJCC v8 | IIIB 期卵巢癌 AJCC v8 | IIIC 期卵巢癌 AJCC v8 | IV 期卵巢癌 AJCC v8 | IVA 期卵巢癌 AJCC v8 | IVB 期卵巢癌 AJCC v8 | POLD1基因突变 | 极点基因突变 | 局部晚期实体瘤美国
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)撤销IV 期乳腺癌 | 复发性乳腺癌
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Cancer Trials Ireland终止转移性乳腺癌 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | 不可切除的乳腺癌爱尔兰, 西班牙
-
National Cancer Institute (NCI)完全的
-
MedSIRHoffmann-La Roche完全的晚期乳腺癌 | 转移性乳腺癌 | 三阴性乳腺癌西班牙, 法国, 英国, 德国, 意大利
-
Shanghai OriginCell Therapeutics Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine招聘中
-
Texas Tech University Health Sciences Center, El...撤销乳腺癌 | 转移性乳腺癌 | HER-2阳性乳腺癌 | ER阳性乳腺癌
-
ZionexaGE Healthcare; Simbec-Orion Group; Keosys招聘中
-
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.招聘中
-
University of LouisvilleJames Graham Brown Cancer Center招聘中
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.招聘中
-
SOLTI Breast Cancer Research GroupRoche Pharma AG招聘中
-
Shandong Cancer Hospital and Institute尚未招聘
-
Minerva Biotechnologies CorporationCity of Hope Medical Center招聘中
-
Medical College of WisconsinLoyola University Chicago招聘中